Head-to-head · Value Score
Vitara RX vs KERNX Health
Two GLP-1 deals, scored on the same six factors. Vitara RX lands a Value Score of 91, KERNX Health a 73. Here's who gives you the honest lower price — and where each one bites back.
Vitara RX
#4 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameKERNX Health
#172 · Grade C+ · Watch List
Est. first month
From $129/mo (plus a separate fee, compounded)
Save ~90% vs brand-nameThe verdict
Vitara RX takes it on Value Score, 91 to 73 — an est. $99/mo first month, with no teaser step-up baked in. KERNX Health isn't out of it: Shoppers who want plan pricing published up front and month-to-month billing.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Vitara RX | KERNX Health |
|---|---|---|
| Value Score | 91 (A) | 73 (C+) |
| Est. first month | $99/mo | From $129/mo (plus a separate fee, compounded) |
| Save vs brand-name | ~93% | ~90% |
| Semaglutide | $99/mo | From $129/mo (plus a separate fee, compounded) |
| Tirzepatide | $149/mo | From $199/mo (plus a separate fee, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | 49 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Vitara RX
VitaraRx is a direct-to-consumer telehealth marketplace offering compounded semaglutide and tirzepatide at flat per-drug pricing across all doses — no membership or hidden fees.
Why it's a deal
- Among the lowest flat pricing in the market — $99/mo semaglutide and $149/mo tirzepatide, all doses same price
- Names its 503A pharmacy partner (Manifest Pharmacy, Greer SC) — strong supply-chain transparency
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Covers 49 states with an explicit state list, not vague "most states" language
The fine print
- No corporate legal entity disclosed — only the trade name "VitaraRx"
- No named medical director — all clinical decisions made by independent providers (marketplace model)
- All sales final — no medication returns
- Per-vial mg quantity isn't clearly disclosed, making price comparisons harder
- Doesn't ship to Alaska
KERNX Health
Washington DC telehealth platform selling compounded semaglutide and tirzepatide on flat monthly plans, with the physician consultation billed separately per visit.
Why it's a deal
- Publishes plan pricing openly, before any intake or account creation
- Month-to-month with no long-term contract and no multi-month prepayment
- Billing starts only after a licensed provider approves treatment
- LegitScript certification verified against the issued seal, not just the badge
The fine print
- Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
- The consultation fee is charged whether or not a prescription is issued
- Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
- No compounding pharmacy is named anywhere on the site
- Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Vitara RX is ranked on the Vitara RX alternatives board, and the same list for the other side is on alternatives to KERNX Health.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.